1st Quarter - Report

THE DUBERSTEIN GROUP INC. for PFIZER INC.

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

Biosimilar utilization Covid supplemental Immunization information systems and appropriations

LobbyistCovered position, as disclosed
BENJAMIN R HOWARD —
DAVID J SCHIAPPA —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Taxation/Internal Revenue Code TAX

Excise Tax / CICP / VICP

LobbyistCovered position, as disclosed
KATHERINE WINKLER KEATING —
ELIZABETH KELLEY —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Health Issues HCR

Drug pricing MADE Act (H.R.3927/S.2082) TRIPS waiver "Test to Treat" announcement Cancer Moonshot initiative

LobbyistCovered position, as disclosed
BRIAN GRIFFIN —
BENJAMIN R HOWARD —
ELIZABETH KELLEY —
DAVID J SCHIAPPA —

Contacted: HOUSE OF REPRESENTATIVES; White House Office; SENATE

Bills named: S. 2082 (117th), H.R. 3927 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.